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Abstract
Background: Wheeze is a very common respiratory symptom, which is associated with several factors and diseases.
Studies on incidence of new-onset wheeze in general adult populations are rare. The present prospective study
aimed to investigate the incidence rate of new-onset wheeze, and predictors for wheeze, in a general, middle-aged
population.
Methods: Individuals, born 1943–1973, who had participated in a previous Swedish study in 1993 (n = 15,813), were
mailed a new respiratory questionnaire in 2003. The questionnaire, which included items about respiratory
symptoms, atopy, and smoking was answered by 11,463 (72 %). Incidence rates of new-onset wheeze were
calculated. Cox regression analyses were performed with incident wheeze as an event and person-years under
observation as dependent variable.
Results: Among those free of wheeze at baseline (n = 8885), there were 378 new cases of wheeze during the study
period (1993–2003). The incidence rate was 4.3/1000 person-years. The adjusted risk was increased in relation to
smoking (HR 2.1;95 % CI 1.7–2.7), ex-smoking (HR 1.4;95 % CI 1.1–1.9), young age (HR 1.7;95 % CI 1.3–2.2), chronic
bronchitis (HR 2.3;95 % CI 0.96–5.7), and rhinitis (HR 1.8;95 % CI 1.4–2.2) at baseline, and body mass index ≥30 (HR
1.9;95 % CI 1.5–2.6) at follow-up.
Conclusions: This is a unique study that presents an incidence rate for new-onset wheeze in a middle-aged,
general population sample previously free of adult wheeze. The results indicate that new-onset wheeze is quite
common in this age group. Health care staff should bear this in mind since new-onset wheeze could be one of the
earliest symptoms of severe respiratory disease. Special attention should be paid to patients with a smoking history,
chronic bronchitis, rhinitis or obesity.
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Background
Wheeze is a very common respiratory symptom caused
by mechanisms narrowing airway calibre [1]. However,
there are few prospective studies in general populations
of adults where incidence of wheeze has been investi-
gated and almost all of these present cumulative inci-
dences [2–8]. Sometimes, it is not solely “wheeze” that
has been investigated, but wheeze in addition to another
symptom. In some studies, only current wheeze is
investigated and not wheeze at any time during the
study period. This probably leads to an underestimation
of the “true” cumulative incidence as wheeze is a symp-
tom that fluctuates over time. To our knowledge, there
have been no prospective studies in general populations
of adults presenting incidence rates of new cases of just
“wheeze” using person-years.
Several factors and diseases, like asthma, chronic ob-
structive pulmonary disease (COPD), airway infections,
obesity, tumours, and smoking have been associated
with wheeze [1, 9–13]. It is a symptom that in clinical
practice is often used in the diagnostic setting of differ-
ent diseases. It follows that it is of great importance to
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be aware of conditions that can result in wheeze. In
order to find predictors for a symptom or disease it is
essential to conduct prospective studies.
The aim of the current prospective study was to inves-
tigate the incidence rate of new cases of wheeze in a
general, middle-aged population sample, and also the re-
lation of new-onset wheeze to smoking, age, gender,
chronic bronchitis, atopy, rhinitis, and BMI.
Methods
In 1993, we sent 20,000 individuals randomly selected
from a county in western Sweden a short questionnaire
which comprised items about respiratory symptoms and
smoking [14]. They were all born between 1943 and
1973. Those answering the questionnaire were mailed a
follow-up questionnaire in 2003 and the response rate
was 72 % (11,463 out of 15,813) [15]. After exclusion of
four subjects with unreasonable stop smoking data and
52 individuals that could not be linked to the 1993 ques-
tionnaire, 11,407 remained. To get a baseline population
free of wheeze, subjects who at baseline reported adult
(>15 years old) wheeze (n = 2005), or who at follow-up re-
ported year of onset before 1993 (n = 334, 74 % >15 years
old at onset) or reported wheeze but no year of onset
(n = 88) were excluded from the analyses. Subjects report-
ing asthma but not wheeze (n = 95) were also excluded.
An affirmative answer to “Have you been diagnosed as
having asthma by a physician?” and/or “Do you have, or
have you ever had, asthma?” defined asthma [16]. In total,
8885 subjects were included in the study. In the 1993 sur-
vey, there were 12,402 subjects who reported that they
were free of adult asthma and wheeze. The follow-up
questionnaire contained new questions as well as ques-
tions identical to those in the baseline questionnaire. The
study has been approved by the local Committee of Ethics
in Gothenburg (Ö 192–03). Informed consent was ob-
tained from all study participants.
Wheeze was defined as a positive answer to the follow-
ing question: “Have you, since the age of 15, ever had
whistling or wheezing in your chest?” It was followed by
a question: “How old were you when these symptoms
started?” The same questions were used in an incident
study of wheeze among bleachery workers performed by
our research group [17]. To be defined as having chronic
bronchitis, individuals had to answer positively to all
three of the following questions: “Have you, since the
age of 15, suffered from long-standing cough with spu-
tum?,” “If yes, has any period lasted for at least
3 months?,” and “If yes, have you had such periods for at
least 2 consecutive years?” This is in line with the inter-
nationally accepted diagnostic criterion for chronic
bronchitis, of a chronic productive cough for at least
3 months a year for 2 consecutive years [18, 19].
Individuals were classified as having atopy if they gave
a positive answer to “Do you have, or have you ever had,
hay fever?” and/or “Do you have, or have you ever had,
atopic dermatitis?” Rhinitis was defined by a positive an-
swer to “Have you, since the age of 15, ever had nasal
symptoms other than hay fever, like nasal blockage and/
or sneezing without having a cold?” [20]. Smoking status
was checked in both 1993 and 2003 and year of smoke-
start and smoke-stop was asked for. Body mass index
(BMI) was calculated from reported weight and height
in the 2003 questionnaire using the formula BMI =mass
(kg)/(height (m))2.
For most of the analyses, the SAS statistical package,
version 9.2 (SAS Institute, Cary, NC, USA), was used.
The incidence analyses were conducted using STATA
(College Station, TX, USA). Based on reported year of
onset, the incidence rate of wheeze (number of new
cases/1000 person-years) with 95 % confidence intervals
(CIs) was calculated for the study period (1993–2003).
Subjects contributed person-years until onset of wheeze.
Person-years were broken down into non-smoking, smok-
ing, and ex-smoking years, respectively. Ex-smokers con-
tributed smoking years until 2 years after smoking
cessation. Incidence rate ratios were calculated, comparing
smoking person-years with non-smoking person-years
and ex-smoking person-years with non-smoking person-
years, respectively. In the Cox regression analyses (PROC
PHREG), incident wheeze was the event of interest and
person-years under observation the dependent variable.
The models were performed for all years as well as for
smoking, ex-smoking, and non-smoking years, respect-
ively. The explanatory variables used were gender, atopy,
chronic bronchitis, rhinitis, BMI ≥30, and different age
groups (20–30 years, 31–40 years, 41–50 years), which
were simultaneously included. Current smoking and ex-
smoking were included when applying a model with all
subjects. Hazard ratios (HRs) are given with 95 %
CIs. In order to study loss to follow-up, the 8885 in-
dividuals included in the study were compared with
the entire population free of asthma and adult wheeze
at baseline (n = 12,402) using methods described by
Johannessen et al. (2014) [21].
Results
The 8885 subjects who were included in the study repre-
sented a total of 86,955 person-years. The demographic
characteristics of these subjects are shown in Table 1. In
1993, the smoking prevalence was around 25 %. By
2003, it had fallen to 15 %.
During the study period (1993–2003), there were 378
new cases of wheeze. The crude incidence rate was 4.3/
1000 person-years and the cumulative incidence was
around 4 %. Table 2 gives incidence rates and relative
risk of wheeze for women, men, atopics, non-atopics,
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individuals with or without chronic bronchitis, subjects
with or without rhinitis, participants with BMI ≥30 or <30,
and different age groups in relation to smoking. Smoking
seems to increase the risk for incident wheeze in all groups
(cases among subjects with chronic bronchitis were too
few to be analysed) (Table 2).
Table 3 presents the results of Cox regression. The
Table shows an increased relative risk for wheeze among
those who were current smokers or ex-smokers at base-
line, compared to those who were never-smokers. Young
age and having chronic bronchitis were both risk factors
for wheeze, but the increased risk of incident wheeze
among those with chronic bronchitis was only significant
among never-smokers, probably due to small numbers
of subjects (Table 3). Those reporting rhinitis at baseline
also had an increased risk of wheeze. On the other hand,
atopy adjusted for rhinitis did not seem to increase the
risk for wheeze. Among those with rhinitis, atopy was
significantly more common compared to those who were
free of rhinitis (28.2 % vs. 13.3 %). Finally, obesity at
follow-up in 2003 was associated with incident wheeze
(Table 3).
The 8885 individuals that responded to the 2003 ques-
tionnaire were compared with the entire population free
of asthma and adult wheeze at baseline (n = 12,402). Re-
sponse to the 2003 questionnaire was associated with fe-
male sex, older age and non-smoking. However, baseline
prevalence of atopy, rhinitis and chronic bronchitis did
Table 1 Demographic characteristics of the study population at baseline in 1993, by smoking group
Smokers Ex-smokers Never-smokers Alla
Age, years (SD) 37.0 (8.8) 39.9 (7.5) 34.3 (9.1) 36.1 (9.0)
All 24.8 %b (n = 2202) 20 %b (n = 1777) 50.8 %b (n = 4509) 100 % (n = 8885)
Female gender 58.1 % (n = 1279) 49.6 % (n = 881) 51.2 % (n = 2308) 52.5 % (n = 4665)
Atopy 13.1 % (n = 288) 16.9 % (n = 301) 18.5 % (n = 836) 16.8 % (n = 1490)
Rhinitis 23.3 % (n = 513) 27.7 % (n = 493) 22.6 % (n = 1021) 23.9 % (n = 2121)
Chronic bronchitis 0.6 % (n = 13) 0.7 % (n = 12) 0.6 % (n = 25) 0.6 % (n = 52)
BMI ≥30 (2003) 10.2 % (n = 224) 11.4 % (n = 202) 8.8 % (n = 395) 9.7 % (n = 858)
20-30 years old 27.4 % (n = 603) 13.8 % (n = 246) 40.3 % (n = 1815) 31.8 % (n = 2829)
31-40 years old 32.2 % (n = 709) 32.4 % (n = 575) 29.6 % (n = 1335) 30.7 % (n = 2723)
41-50 years old 40.4 % (n = 890) 53.8 % (n = 956) 30.1 % (n = 1359) 37.5 % (n = 3333)
SD standard deviation, BMI body mass index
aIncludes also those with missing smoking data
bPercent of all individuals in the study












(ex- /never- smoking years)
All 4.3 (3.9–4.8) 7.9 (6.8–9.3) 4.2 (3.0–4.7) 3.0 (2.5–3.6) 2.6 (2.1–3.3) 1.3 (0.9–1.7)
Women 4.8 (4.2–5.5) 8.3 (6.8–10.1) 4.8 (3.6–6.3) 2.9 (2.3–3.7) 2.8 (2.1–3.9) 1.6 (1.1–2.4)
Men 3.8 (3.3–4.5) 7.4 (5.6–9.5) 2.9 (2.0–4.1) 3.1 (2.4–3.9) 2.4 (1.6–3.4) 1.4 (0.96–2.1)
Atopic 4.9 (3.8–6.2) 8.2 (5.2–12.5) 5.3 (3.2–8.3) 3.6 (2.4–5.1) 2.3 (1.3–4.2) 1.5 (0.8–2.7)
Non-atopic 4.2 (3.7–4.7) 7.9 (6.6–9.4) 3.5 (2.7–4.5) 2.8 (2.3–3.4) 2.8 (2.1–3.7) 1.3 (0.9–1.7)
Rhinitis 6.6 (5.5–7.8) 11.4 (8.5–14.9) 5.5 (3.8–7.8) 5.0 (3.7–6.6) 2.3 (1.5–3.4) 1.1 (0.7–1.8)
Non-rhinitis 3.6 (3.2–4.1) 7.0 (5.7–8.5) 3.1 (2.3–4.1) 2.5 (2.0–3.1) 2.8 (2.1–3.8) 1.2 (0.8–1.8)
CB (5 cases) 10.0 (3.3–23) 10.1 (0.2–56) 6.2 (0.1–35) 13.4 (2.8–39) — —
Non-CB 4.3 (3.9–4.7) 7.9 (6.7–9.3) 3.8 (3.0–4.7) 3.0 (2.5–3.5) 2.7 (2.1–3.4) 1.3 (0.9–1.7)
BMI ≥30 (2003) 7.6 (5.9–9.8) 14.3 (9.3–21) 6.1 (3.4–10.1) 5.5 (3.4–8.5) 2.6 (1.4–4.8) 1.1 (0.5–2.2)
BMI < 30 (2003) 4.0 (3.5–4.4) 7.3 (6.1–8.6) 3.5 (2.7–4.5) 2.8 (2.3–3.3) 2.6 (2.0–3.4) 1.3 (0.9–1.7)
20–30 years old 5.2 (4.3–6.1) 10.0 (7.6–12.9) 4.8 (2.9–7.6) 3.7 (2.9–4.7) 2.7 (1.9–3.9) 1.3 (0.7–2.2)
31–40 years old 3.6 (2.9–4.4) 6.4 (4.6–8.7) 3.2 (2.0–7.6) 2.5 (1.7–3.6) 2.5 (1.6–4.1) 1.3 (0.7–2.2)
41–50 years old 4.2 (3.5–5.0) 7.7 (5.9–9.8) 3.8 (2.8–5.2) 2.6 (1.8–3.6) 3.0 (1.9–4.7) 1.5 (0.9–2.4)
The data are presented as incidence rates (cases/1000 person-years) and relative risks, by smoking exposure (95 % confidence intervals). Atopy, rhinitis, CB, and
age at baseline in 1993, and BMI in 2003, respectively
CB chronic bronchitis, BMI body mass index
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not differ when comparing responders to the 2003 ques-
tionnaire with all baseline participants free of asthma
and adult wheeze. The associations of age, sex, and
smoking habits with the respiratory outcomes chronic
bronchitis and rhinitis at baseline did not differ signifi-
cantly when comparing the two populations.
Discussion
This prospective study in a middle-aged, general popula-
tion showed an incidence rate of 4.3/1000 person-years
for new-onset adult wheeze, giving a cumulative inci-
dence of approximately 4 % during the study period.
Smoking doubled the risk of incident wheeze and ex-
smoking was associated with a 40 % increased risk.
Young age, chronic bronchitis, and rhinitis were also
predictors for incident wheeze. In addition, obesity at
follow-up was associated with an increased risk of inci-
dent wheeze.
To our knowledge, the current study is the first to re-
port an incidence rate of new-onset wheeze based on
person-years in an adult, general population sample pre-
viously free of adult wheeze. An observed incidence rate
is dependent on the baseline population and it has been
shown that the composition of this population is of great
importance when estimating asthma incidence in pro-
spective studies, and probably the same will be true
when incidence of wheeze is studied [22]. An accurate
incidence rate also relies on correct reporting of previ-
ous symptoms [23]. In our study, we excluded all sub-
jects with previous self-reported wheeze since the age of
15 and/or who had ever had asthma, which is essential
for a correct incidence rate of new-onset adult wheeze.
Even the characterization of the outcome is significant.
Few prospective studies have investigated incidence of
wheeze in general adult populations [2–8] and some-
times it is not just “wheeze” that has been investigated,
but wheeze in addition to another symptom or an
asthma diagnosis that has been equated with wheeze.
Most of the studies only present cumulative incidence.
In an approximately 30-year, follow-up Scottish study of
subjects aged 39–45 years and free of childhood wheez-
ing, 11.5 % of 1542 reported adult onset wheeze [5]. This
is similar to our results given that our data is adjusted to
a longer study period. A British cohort study of individ-
uals born during 1 specific week in 1958 reported a cu-
mulative incidence for wheeze without asthma of 10.5 %
when those free of wheeze and asthma were followed be-
tween the ages of 34 and 42 years [7]. It is difficult to
compare these results with the results from our study
since the British study investigated individuals born dur-
ing a specific week and we studied a general population
with a wide age range. Hedlund et al. report a 10-year
cumulative incidence of wheeze of 10 % in a population-
based study from northern Sweden [6]. The divergent
results, compared to our study, could perhaps be ex-
plained by different exclusion criteria at baseline where
Hedlund et al. seem to have excluded only those with
present wheeze. In a general population study from our
research group, 3.3 % of 1506 subjects reported new-
onset wheeze during a 4 year follow-up [8], which is a
higher incidence than in the current study. In the
present study, subjects were followed for a longer period
of time and some individuals with minor and transient
wheeze early during the study period may have forgotten
their symptoms. However, analysing year of onset of
wheeze did not support this hypothesis because new
cases were relatively evenly distributed over the study
period (data not shown). Dodge and Burrows present
high incidence rates for new-onset “attacks of shortness
of breath with wheeze” in a random sample of non-
Mexican,-white American households in Tucson, Arizona,
USA, followed for approximately 3.5 years [2]. More than
10 % of their population developed “attacks of shortness
of breath with wheeze” during the study period. It appears
Table 3 Hazard ratios based on Cox regression analysis of adult new-onset wheeze, by smoking exposure
Smoking years Ex-smoking years Never-smoking years All
Current smoking at baselineb NAa NAa NAa 2.1 (1.7–2.7)
Ex-smoking at baselineb NAa NAa NAa 1.4 (1.1–1.9)
Female genderb 1.1 (0.8–1.5) 1.6 (0.99–2.4) 0.9 (0.7–1.3) 1.1 (0.9–1.4)
Rhinitis at baselineb 1.7 (1.2–2.4) 1.6 (1.0–2.6) 2.0 (1.4–2.9) 1.8 (1.4–2.2)
Atopic at baselineb 0.9 (0.5–1.4) 1.3 (0.8–2.3) 1.1 (0.7–1.6) 1.0 (0.8–1.3)
CB at baselineb 1.2 (0.2–8.9) 1.7 (0.2–12.6) 4.5 (1.4–14) 2.3 (0.96–5.7)
20–30 years at baselineb 1.7 (1.1–2.5) 1.8 (0.9–3.4) 1.5 (1.0–2.4) 1.7 (1.3–2.2)
41–50 years at baselineb 1.2 (0.8–1.8) 1.5 (0.8–2.5) 1.1 (0.6–1.7) 1.2 (0.9–1.6)
BMI ≥30 (2003)b 2.1 (1.4–3.2) 1.9 (1.1–3.4) 2.0 (1.2–3.2) 1.9 (1.5–2.6)
The data are presented as hazard ratios (95 % confidence intervals), based on Cox regression analysis. One Cox regression model per column. Atopy, rhinitis, CB,
and age at baseline in 1993, and BMI in 2003, respectively
CB chronic bronchitis, BMI body mass index
aNA = not applicable
b1 = yes, and 0 = no
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that the subjects could have entered the incident study
even if they had reported wheeze without shortness of
breath at baseline. This could, of course, have contributed
to the high incidence rate found.
Apart from the interest in an accurate incidence rate
of new-onset wheeze we also wanted to study predictors
of wheeze. Smoking has been reported to be associated
with wheeze, especially in women [13]. Our prospective
study revealed smoking as a strong predictor for wheeze
in both sexes. Smoking doubled the risk of wheeze and
subjects who had stopped smoking had an increased risk
of around 40 % for incident wheeze. A positive trend
was that the smoking prevalence among the participants
of our study had fallen from 25 % in 1993 to 15 % in
2003, which certainly affects the total incidence rate of
wheeze.
In the current study, few subjects with chronic bron-
chitis were included. Many individuals with chronic
bronchitis in 1993 were excluded from the present study
as they also reported asthma and/or wheeze. Neverthe-
less, chronic bronchitis at baseline was a significant risk
factor for future wheeze in never-smoking subjects.
Chronic bronchitis is dependent on bronchial hyper-
secretion, and has been closely related to COPD, which
may explain the association with wheeze [12].
We found that a high BMI at follow-up was associated
with incident wheeze, which is in line with a cross-
sectional study where an association was found between
severe obesity and wheeze [10]. Interestingly, the authors
of that study did not find any increased airway respon-
siveness or airway obstruction in the obese group com-
pared with a normal BMI group. In a report from the
American Thoracic Society, it was concluded that obes-
ity and asthma are closely associated, but that obesity
only has a small impact on airway hyper responsiveness
and airway obstruction (ratio of forced expiratory vol-
ume in 1 s to the forced vital capacity of the lungs
(FEV1/FVC ratio)) [24]. It therefore seems that obesity is
related to respiratory symptoms like wheeze, but also to
an asthma diagnosis.
In our study, the youngest age group (20–30 years at
baseline) had a significantly increased risk for incident
wheeze. This is in contrast to previous studies where in-
cidence of wheeze increased with age [2, 4, 6]. However,
compared to our cohort, the mean age in two of these
study populations was approximately 12 years and
16 years higher, respectively, which makes comparisons
difficult [4, 6]. We could also see a trend for an in-
creased incidence of wheeze in subjects aged 41–50
years at baseline compared with subjects aged 31–40
years, which is in line with these previous findings.
Rhinitis, but not atopy defined as ever had hay fever
or atopic dermatitis, at baseline was associated with
new-onset wheeze in the current study. Among those
with rhinitis, there were more than twice as many with
atopy compared to those free of rhinitis. Atopy is related
to asthma and often, allergic rhinitis precedes the asthma
diagnosis [25, 26]. However, even non-allergic rhinitis is a
potent predictor of adult-onset asthma [25, 26]. In our
study, all individuals with wheeze at baseline, including
those with atopy, were excluded. This means that subjects
with ever hay fever or atopic dermatitis, even during child-
hood, who had developed wheeze or asthma, were ex-
cluded. The remaining individuals with atopy therefore
represented a select group and it seems that adults with
atopy are not at risk of developing new-onset wheeze.
However, the increased risk for wheeze in those with rhin-
itis may reflect asthma not yet diagnosed [26].
Socio-economic status and environmental factors
other than smoking have been associated with wheeze
[5, 6, 27]. It would have been very interesting to study
these presumptive predictors of new-onset wheeze, but
we do not have baseline information about these factors.
The prospective design of the present study allows the
identification of predictors of incident wheeze, and it
also reduces recall bias. The high response rate among
the large number of subjects invited to participate in-
creases the potential for the study population to repre-
sent the target population. However, selection bias is a
problem in epidemiological studies. In the literature, stud-
ies comparing prevalence of respiratory symptoms and
airway diseases between responders and non-responders,
respectively, diverge in their findings [28–30], and it has
been suggested that all studies should include analysis of
non-responders [31]. In our 1993 survey, non-response
was associated with lower age, male sex, being
foreign-born, being unmarried, unemployment, and
low income [14]. Response to the 2003 questionnaire
was related to older age, female sex and non-smoking.
However, it seems that exclusion of those lost to follow-
up did not alter the prevalence of respiratory symptoms
or exposure-outcome associations at baseline. Despite
some limitations of the current study, there are good rea-
sons to believe that the results of the study could be valid
for other, similar populations.
Conclusions
The present prospective study is unique as it presents
an incidence rate for new-onset wheeze in a middle-
aged, general population previously free of adult
wheeze. The results indicate that new-onset wheeze is
quite common in middle-aged people. It is thus im-
portant for health care staff to be aware of this fact
since new-onset wheeze could be the first sign of se-
vere respiratory diseases, like COPD, asthma, airway
infections, and tumours. Special attention should be
paid to patients with a smoking history, chronic bron-
chitis, rhinitis or obesity.
Holm et al. BMC Pulmonary Medicine  (2015) 15:163 Page 5 of 6
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
MH, KT and EA had full access to all the data in the study and take
responsibility for the integrity of the data and the accuracy of the data
analysis. MH, KT and EA, drafting the manuscript for important intellectual
content and interpretation of data. EA and MH analysis of data. KT
conception and design. All authors read and approved the final manuscript.
Acknowledgements
The study received financial support from the Swedish Research Council for
Health, Working Life, and Welfare (Forte) and the Swedish Heart and Lung
Foundation.
Author details
1Department of Occupational and Environmental Medicine, Sahlgrenska
University Hospital, Box 414, SE 40530 Gothenburg, Sweden. 2Section of
Occupational and Environmental Medicine, Institute of Medicine, Sahlgrenska
Academy, University of Gothenburg, Box 414, SE 40530 Gothenburg, Sweden.
Received: 7 July 2015 Accepted: 10 December 2015
References
1. Meslier N, Charbonneau G, Racineux J-L. Wheezes. Eur Respir J. 1995;8:1942–8.
2. Dodge RR, Burrows B. The prevalence and incidence of asthma and asthma-
like symptoms in a general population sample. Am Rev Respir Dis. 1980;122:
567–75.
3. Krzyzanowski M, Jedrychowski W. Occupational exposure and incidence of
chronic respiratory symtoms among residents of Cracow followed for 13
years. Int Arch Occup Environ Health. 1990;62:311–7.
4. Sparrow D,O, Connor GT, Basner RC, Rosner B, Weiss ST. Predictors of the
new onset of wheezing among middle-aged and older men. The
Normative Aging Study. Am Rev Respir Dis. 1993;147:367–71.
5. Bodner C, Ross S, Douglas G, Little J, Legge J, Friend J, et al. The prevalence
of adult onset wheeze: longitudinal study. BMJ. 1997;314:792–3.
6. Hedlund U, Eriksson K, Rönmark E. Socio-economic status is related to
incidence of asthma and respiratory symptoms in adults. Eur Respir J. 2006;
28:303–10.
7. Butland BK, Strachan DP. Asthma onset and relapse in adult life: the British
1958 birth cohort study. Ann Allergy Asthma Immunol. 2007;98:337–43.
8. Olin AC, Rosengren A, Thelle DS, Lissner L, Torén K. Increased fraction of
exhaled nitric oxide predicts new-onset wheeze in a general population.
Am J Respir Crit Care Med. 2010;181:324–7.
9. Mckean MC, Leech M, Lambert PC, Hewitt C, Myint S, Silverman M. A model
of viral wheeze in nonasthmatic adults: symptoms and physiology. Eur
Respir J. 2001;18:23–32.
10. Schachter LM, Salome CM, Peat JK, Woolcock AJ. Obesity is a risk for asthma
and wheeze but not airway hyperresponsiveness. Thorax. 2001;56:4–8.
11. Court CS, Cook DG, Strachan DP. Comparative epidemiology of atopic and
non-atopic wheeze and diagnosed asthma in a national sample of English
adults. Thorax. 2002;57:951–7.
12. From the Global Strategy for the Diagnosis, Management and Prevention of
COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2015.
Available from: http://www.goldcopd.org/
13. Bjerg A, Ekerljung L, Eriksson J, Ólafsdóttir IS, Middelveld R, Franklin KA, et al.
Higher risk of wheeze in female than malesmokers. Results from the Swedish
GA 2 LEN study. PLoS One. 2013;8:e54137. doi:10.1371/journal.pone.0054137.
14. Toren K, Hermansson BA. Incidence rate of adult-onset asthma in relation to
age, sex, atopy and smoking: a Swedish population-based study of 15 813
adults. Int J Tuberc Lung Dis. 1999;3:192–7.
15. Holm M, Torén K, Andersson E. Incidence of chronic bronchitis: a prospective
study in a large general population. Int J Tuberc Lung Dis. 2014;18:870–5.
16. Toren K, Brisman J, Järvholm B. Asthma and asthma-like symptoms in adults
assessed by questionnaires. Chest. 1993;104:600–8.
17. Andersson E, Olin A-C, Hagberg S, Nilsson R, Nilsson T, Toren K. Adult-onset
asthma and wheeze among irritant-exposed bleachery workers. Am J Ind
Med. 2003;43:532–8.
18. Ciba Guest Symposium. Terminology, definitions, and classification of
chronic pulmonary emphysema and related conditions. Standardized
questionnaires of respiratory symptoms. Thorax. 1959;14:286–99.
19. ATS statement. Standards for the diagnosis and care of patients with
chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1995;
152(5Pt2):S77–S121.
20. Hellgren J, Lillienberg L, Jarlstedt J, Karlsson G, Toren K. Population-based
study of non-infectious rhinitis in relation to occupational exposure, age,
sex, and smoking. Am J Ind Med. 2002;42:23–8.
21. Johannessen A, Verlato G, Benediktsdottir B, Forsberg B, Franklin K, Gislason
T, et al. Longterm follow-up in European respiratory health studies -
patterns and implications. BMC Pulm Med. 2014;14:63.
22. Torén K, Gislason T, Omenaas E, Jögi R, Forsberg B, Nyström L, et al. A
prospective study of asthma incidence and its predictors: the RHINE study.
Eur Respir J. 2004;24:942–6.
23. Järvholm B, Brisman J, Torén K. The association between epidemiological
measures of the occurrence of asthma. Int J Tuberc Lung Dis. 1998;2:1029–36.
24. Dixon AE, Holguin F, Sood A, Salome CM, Pratley RE, Beuther DA, et al.
American thoracic society ad hoc subcommitte on obesity and lung
disease. Proc Am Thorac Soc. 2010;7:325–35.
25. Toren K, Olin A-C, Hellgren J, Hermansson B-A. Rhinitis increase the risk for
adult-onset asthma- a Swedish population-based case-control study (MAP-study).
Respir Med. 2002;96:635–41.
26. Shaaban R, Zureik M, Soussan D, Neukirch C, Heinrich J, Sunyer J, et al.
Rhinitis and onset of asthma: a longitudinal population-based study. Lancet.
2008;372:1049–57.
27. Mendell MJ, Mirer AG, Cheung K, Tong M, Douwes J. Respiratory and allergic
health effects of dampness, mold, and dampness-related agents: a review of
the epidemiologic evidence. Environ Health Perspect. 2011;119:748–56.
28. Rönmark EP, Ekerljung L, Lötvall J, Torén K, Rönmark E, Lundbäck B. Large
scale questionnaire survey on respiratory health in Sweden: Effects of late- and
non-response. Respir Med. 2009;103:1807–15.
29. Kotaniemi JT, Hassi J, Kataja M, et al. Does non-responder bias have a
significant effect on the results in a postal questionnaire study? Eur J
Epidemiol. 2001;17:809–17.
30. Rönmark E, Lundqvist A, Lundbäck B, Nyström L. Non-responders to a
postal questionnaire on respiratory symptoms and diseases. Eur J Epidemiol.
1999;15:293–9.
31. Bakke PS. Non-response in epidemiological studies- How to cope with it?
Respir Med. 2010;104:323–4.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Holm et al. BMC Pulmonary Medicine  (2015) 15:163 Page 6 of 6
